| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.1B | $0.1B | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.0B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.08 | $-0.16 | $0.11 | $0.16 | $0.08 | $0.04 |
| EPS (Diluted) | $0.08 | $-0.16 | $0.11 | $0.16 | $0.08 | $0.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $2.6B | $2.3B | $1.9B | $1.6B | $1.1B | $0.7B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — |
| Total Liabilities | $1.2B | $0.9B | $0.7B | $0.5B | $0.3B | $0.2B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $1.4B | $1.3B | $1.3B | $1.0B | $0.8B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-0.5B | $-0.5B | $-0.4B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $0.3B | $0.3B | $0.3B | $0.5B | $0.3B | $0.3B |